Assessment Considerations in Older Adults

  • Cheryl A. SadowskiEmail author


Assessment of older adults, particularly those who are multimorbid, complex, or frail, requires a broader interprofessional assessment. This approach is referred to as comprehensive geriatric assessment and includes health and non-health domains. The assessment is completed with an interprofessional team, and the process focuses on the functional abilities and values and goals of the patient, rather than cure or simply chronic disease management. The assessment has many domains, including cognition, function through activities of daily living, nutrition, social supports, and others. Pharmacists have an important role to play in contributing to the geriatric assessment through feedback on functional performance of the patient and through assessment of medications. Medications can be assessed for appropriateness through explicit and implicit criteria, with the Beers criteria being the most universally applied. Functional management of medications is also an important aspect to measure, and while there are many tools to measure this, there are few that can be integrated into daily practice. The wide variety of tools and resources available can support pharmacists in contributing to the geriatric assessment through an interprofessional team or through an individual practice in a community.


Geriatrics Aged Older adults Comprehensive geriatric assessment Interprofessional Geriatric syndromes Multimorbidity Function Cognition Medication appropriateness Medication management 


  1. 1.
    Morley JE. A brief history of geriatrics. J Gerontol A Biol Sci Med Sci. 2004;59(11):1132–52.PubMedCrossRefGoogle Scholar
  2. 2.
    Hazzard WR. Commentary: geriatrics: specialty, subspecialty, or supraspecialty? J Gerontol A Biol Sci Med Sci. 2004;59(11):1161–2; discussion 1132–52PubMedCrossRefGoogle Scholar
  3. 3.
    Ekerdt DJ. Gerontology in five images. Gerontologist. 2016;56(2):184–92.PubMedCrossRefGoogle Scholar
  4. 4.
    Lundebjerg NE, Trucil DE, Hammond EC, Applegate WB. When it comes to older adults, language matters: journal of the American geriatrics society adopts modified American medical association style. J Am Geriatr Soc. 2017;65(7):1386–8.PubMedCrossRefGoogle Scholar
  5. 5.
  6. 6.
    United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2017 revision, key findings and advance tables. Working Paper No. ESA/P/WP/248. 2017.Google Scholar
  7. 7.
    Statistics Canada. Census in brief: a portrait of the population aged 85 and older in 2016 in Canada. Catalogue no. 98-200-X2016004. May 3, 2017. [cited June 22, 2018]. Available from:
  8. 8.
    Canadian Institute for Health Information. Drug use among seniors in Canada, 2016. Ottawa: CIHI; 2018.Google Scholar
  9. 9.
    Qato DM, Wilder J, Schumm L, Gillet V, Alexander G. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473–82.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    CDC. Hospitalizations among the elderly. JAMA. 2015;313(10):1005.Google Scholar
  11. 11.
    Rotterman M. High use of acute care hospital services at age 50 or older. Health Reports 2017. Catalogue no. 82-003-X:1–16. Sept 20, 2017.Google Scholar
  12. 12.
    Canadian Institute for Health Information (CIHI). National Health Expenditures: how has health spending on seniors changed? Ottawa: The Institute; 2015. [cited June 22, 2018]. Available from: Scholar
  13. 13.
    Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition—multimorbidity. JAMA. 2012;307(23):2493–4.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Carlson C, Merel SE, Yukawa M. Geriatric syndromes and geriatric assessment for the generalist. Med Clin North Am. 2015;99(2):263–79.PubMedCrossRefGoogle Scholar
  15. 15.
    Hajjar ER, Gray SL, Slattum PW, Hersh LR, Naples JG, Hanlon JT. Chapter: geriatrics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy, a pathophysiologic approach. 10th ed. New York: McGraw-Hill; 2017.Google Scholar
  16. 16.
    Hubbard RE, O’Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013;69(3):319–26.PubMedCrossRefGoogle Scholar
  17. 17.
    Boparai MK, Korc-Grodzicki B. Prescribing for older adults. Mt Sinai J Med. 2011;78(4):613–26.PubMedCrossRefGoogle Scholar
  18. 18.
    Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007;5(3):263–303.PubMedCrossRefGoogle Scholar
  20. 20.
    Amella EJ. Presentation of illness in older adults. If you think you know what you’re looking for, think again. AORN J. 2006;83(2):372–4; 377–82, 385–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Rehman H, Qazi S. Atypical manifestations of medical conditions in the elderly. CGS J CME. 2013;3(1):17–24.Google Scholar
  22. 22.
    Palmer K, Onder G. Comprehensive geriatric assessment: benefits and limitations. Eur J Intern Med. 2018;54:e8–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Elsawy B, Higgins KE. The geriatric assessment. Am Fam Physician. 2011;83(1):48–56.PubMedGoogle Scholar
  24. 24.
    Pilotto A, Cella A, Pilotto A, Daragjati J, Veronese N, Musacchio C, et al. Three decades of comprehensive geriatric assessment: evidence coming from different healthcare settings and specific clinical conditions. J Am Med Dir Assoc. 2017;18(2):192.e1–192.e11.CrossRefGoogle Scholar
  25. 25.
    Rhalimi F, Rhalimi M, Rauss A. Pharmacist’s comprehensive geriatric assessment: introduction and evaluation at elderly patient admission. Drugs Real World Outcomes. 2017;4(1):43–51.PubMedCrossRefGoogle Scholar
  26. 26.
    Ellis G, Whitehead MA, O’Neill D, Langhorne P, Robinson D. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2011;7:006211.Google Scholar
  27. 27.
    Parker SG, McLeod A, McCue P, Phelps K, Bardsley M, Roberts HC, et al. New horizons in comprehensive geriatric assessment. Age Ageing. 2017;46(5):713–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Agrell B, Dehlin O. The clock-drawing test. Age Ageing. 1998;27(3):399–403.CrossRefGoogle Scholar
  31. 31.
    Bowie CR, Harvey PD. Administration and interpretation of the trail making test. Nat Protoc. 2006;1(5):2277–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Braun M, Tupper D, Kaufmann P, McCrea M, Postal K, Westerveld M, et al. Neuropsychological assessment: a valuable tool in the diagnosis and management of neurological, neurodevelopmental, medical, and psychiatric disorders. Cogn Behav Neurol. 2011;24(3):107–14.PubMedCrossRefGoogle Scholar
  33. 33.
    Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982–1983;17(1):37–49.CrossRefGoogle Scholar
  34. 34.
    Greenberg SA. How to try this: the geriatric depression scale: short form. Am J Nurs. 2007;107(10):60–9. quiz 69–70.PubMedCrossRefGoogle Scholar
  35. 35.
    Harwood DG, Ownby RL, Barker WW, Duara R. The factor structure of the Cornell scale for depression in dementia among probable Alzheimer’s disease patients. Am J Geriatr Psychiatry. 1998;6(3):212–20.PubMedGoogle Scholar
  36. 36.
    Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10(1):20–30.PubMedCrossRefGoogle Scholar
  37. 37.
    Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.PubMedCrossRefGoogle Scholar
  38. 38.
    Turner-Stokes L, Nyein K, Turner-Stokes T, Gatehouse C. The UK FIM+FAM: development and evaluation. Functional assessment measure. Clin Rehabil. 1999;13(4):277–87.PubMedCrossRefGoogle Scholar
  39. 39.
    Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Kwan E, Straus SE. Assessment and management of falls in older people. CMAJ. 2014;186(16):E610–21.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Duong E, Chaudry S, Marin H, Gong C, Tsuyuki R, Al Hamarneh Y, Sadowski CA. Case finding for geriatric syndromes in community pharmacies. American Geriatrics Society Annual Scientific Meeting. Orlando, FL, USA. May 3–5, 2018. JAGS. 2018;66(Suppl 2):S318.Google Scholar
  42. 42.
    Park H, Satoh H, Miki A, Urushihara H, Sawada Y. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429–40.PubMedCrossRefGoogle Scholar
  43. 43.
    Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging. 2012;29(5):359–76.PubMedCrossRefGoogle Scholar
  44. 44.
    Rolita L, Spegman A, Tang X, Cronstein BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013;61(3):335–40.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Soderberg KC, Laflamme L, Moller J. Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs. 2013;27(2):155–61.PubMedCrossRefGoogle Scholar
  46. 46.
    Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Zang G. Antihypertensive drugs and the risk of fall injuries: a systematic review and meta-analysis. J Int Med Res. 2013;41(5):1408–17.PubMedCrossRefGoogle Scholar
  48. 48.
    Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc. 1986;34(2):119–26.PubMedCrossRefGoogle Scholar
  49. 49.
    Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil. 1986;67(6):387–9.PubMedGoogle Scholar
  50. 50.
    Duncan PW, Weiner DK, Chandler J, Studenski S. Functional reach: a new clinical measure of balance. J Gerontol. 1990;45(6):M192–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30.PubMedCrossRefGoogle Scholar
  52. 52.
    Basra R, Artibani W, Cardozo L, Castro-Diaz D, Chapple C, Cortes E, et al. Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ). Eur Urol. 2007;52(1):230–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery E, et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol. 1995;154(5):1770–4.PubMedCrossRefGoogle Scholar
  54. 54.
    Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG. Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther. 2005;22(4):381–94.PubMedCrossRefGoogle Scholar
  55. 55.
    Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, et al. Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919–24.PubMedCrossRefGoogle Scholar
  56. 56.
    Vellas B, Villars H, Abellan G, Soto ME, Rolland Y, Guigoz Y, et al. Overview of the MNA–its history and challenges. J Nutr Health Aging. 2006;10(6):456–63; discussion 463–5.Google Scholar
  57. 57.
    Tinetti M, Huang A, Molnar F. The geriatrics 5M’s: a new way of communicating what we do. J Am Geriatr Soc. 2017;65(9):2115.PubMedCrossRefGoogle Scholar
  58. 58.
    Anon. Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. Canadian task force on the periodic health examination. CMAJ. 1995;152(8):1211–22.Google Scholar
  59. 59.
    Mulrow CD, Lichtenstein MJ. Screening for hearing impairment in the elderly: rationale and strategy. J Gen Intern Med. 1991;6(3):249–58.PubMedCrossRefGoogle Scholar
  60. 60.
    Weinstein BE, Spitzer JB, Ventry IM. Test-retest reliability of the hearing handicap inventory for the elderly. Ear Hear. 1986;7(5):295–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Lucchetti G, Bassi RM, Lucchetti ALG. Taking spiritual history in clinical practice: a systematic review of instruments. Explore (NY). 2013;9(3):159–70.CrossRefGoogle Scholar
  62. 62.
    Lee SS, Schwemm AK, Reist J, Cantrell M, Andreski M, Doucette WR, et al. Pharmacists’ and pharmacy students’ ability to identify drug-related problems using TIMER (Tool to improve medications in the elderly via review). Am J Pharm Educ. 2009;73(3):52.PubMedCrossRefGoogle Scholar
  63. 63.
    Lewis T. Using the NO TEARS tool for medication review. BMJ. 2004;329(7463):434.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Courtney DL. Medication reduction strategies. Compr Ther. 1996;22(5):318–23.PubMedGoogle Scholar
  65. 65.
    Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med. 2013;18(4):121–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Barenholtz LH. Self-administered medication-risk questionnaire in an elderly population. Ann Pharmacother. 2003;37(7–8):982–7.Google Scholar
  67. 67.
    Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.PubMedCrossRefGoogle Scholar
  68. 68.
    Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55(Suppl 2):S373–82.PubMedCrossRefGoogle Scholar
  69. 69.
    By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(ail):2227–46.CrossRefGoogle Scholar
  70. 70.
    O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Levy HB, Marcus EL, Christen C. Beyond the beers criteria: a comparative overview of explicit criteria. Ann Pharmacother. 2010;44(12):1968–75.PubMedCrossRefGoogle Scholar
  72. 72.
    Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.PubMedCrossRefGoogle Scholar
  73. 73.
    Elliott RA, Marriott JL. Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Edelberg HK, Shallenberger E, Wei JY. Medication management capacity in highly functioning community-living older adults: detection of early deficits. J Am Geriatr Soc. 1999;47(5):592–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Manias E, Beanland CJ, Riley RG, Hutchinson AM. Development and validation of the self-administration of medication tool. Ann Pharmacother. 2006;40(6):1064–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.University of Alberta, Faculty of Pharmacy and Pharmaceutical SciencesEdmontonCanada

Personalised recommendations